Isembyld
- Fitness & Movement
FDA Approves First Myostatin Inhibitor for Spinal Muscular Atrophy
The FDA has approved Isembyld, the first myostatin inhibitor, for spinal muscular atrophy patients. This marks a milestone in muscle-regulation…
Read More »
